Previous close | 0.1571 |
Open | 0.1620 |
Bid | 0.0000 x 0 |
Ask | 0.1531 x 100 |
Day's range | 0.1531 - 0.1669 |
52-week range | 0.1360 - 1.0100 |
Volume | |
Avg. volume | 616,537 |
Market cap | 15.355M |
Beta (5Y monthly) | 0.50 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.2700 |
Earnings date | 08 May 2024 - 13 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
To the annoyance of some shareholders, Pieris Pharmaceuticals, Inc. ( NASDAQ:PIRS ) shares are down a considerable 27...
Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...
Pieris Pharmaceuticals (PIRS) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.